npj Parkinson's Disease (Nov 2024)

Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein

  • Mariangela Massaro Cenere,
  • Marta Tiberi,
  • Emanuela Paldino,
  • Sebastian Luca D’Addario,
  • Mauro Federici,
  • Cecilia Giacomet,
  • Debora Cutuli,
  • Alessandro Matteocci,
  • Francesca Cossa,
  • Beatrice Zarrilli,
  • Nicolas Casadei,
  • Ada Ledonne,
  • Laura Petrosini,
  • Nicola Berretta,
  • Francesca Romana Fusco,
  • Valerio Chiurchiù,
  • Nicola B. Mercuri

DOI
https://doi.org/10.1038/s41531-024-00824-w
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Increasing efforts have been made to elucidate how genetic and environmental factors interact in Parkinson’s disease (PD). In the present study, we assessed the development of symptoms on a genetic PD rat model that overexpresses human α-synuclein (Snca +/+) at a presymptomatic age, exposed to a pro-inflammatory insult by intraperitoneal injection of lipopolysaccharide (LPS), using immunohistology, high-dimensional flow cytometry, constant potential amperometry, and behavioral analyses. A single injection of LPS into WT and Snca +/+ rats triggered long-lasting increase in the activation of pro-inflammatory microglial markers, monocytes, and T lymphocytes. However, only LPS Snca +/+ rats showed dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc), associated with a reduction in the release of evoked dopamine in the striatum. No significant changes were observed in the behavioral domain. We propose our double-hit animal as a reliable model to investigate the mechanisms whereby α-synuclein and inflammation interact to promote neurodegeneration in PD.